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a  b  s  t  r  a  c  t
Background/Aim:  In this  study,  we  investigated  the  effect  of rectal gas  on  the  dose  distribution  of  prostate
cancer  using  a  volumetric  modulated  arc  therapy  (VMAT)  treatment  planning.
Materials  and  Methods:  The  first is  the original  structure  set, clinical  target  volume  (CTV),  the  rectum,
and  the  bladder  used  clinically.  The  second  is  a structure  set  (simulated  gas  structure  set)  in which  the
overlapping  part  of  the  rectum  and  PTV  is  overwritten  with  Hounsfield  Unit −950  as gas. Full  arc and
limited  gantry  rotation  angle  with  VMAT  were  the two  arcs.  The  VMAT  of  the  full  arc was  181◦–179◦ in
the  clockwise  (CW)  direction  and  179◦–181◦ in the  counterclockwise  (CCW)  direction.  Three  partial  arcs
with  a limited  gantry  rotation  angle  were  created:  200◦–160 ◦CW  and  160◦–200 ◦CCW;  220◦–140 ◦CW
and  140◦–220 ◦CCW;  and  finally,  240◦–120 ◦CW  and 120◦–240 ◦CCW.  The  evaluation  items  were  dose
difference,  distance  to  agreement,  and gamma  analysis.
Result:  In  the  CTV,  the  full  arc was  the treatment  planning  technique  with  the least  effect  of  rectal  gas.  In the
rectum,  when  the  gantry  rotation  angle  range  was  short,  the  pass  rate  tended  to reduce  for  all  evaluation
indices.  The  bladder  showed  no  characteristic  change  between  the treatment  planning  techniques  in  any
of the evaluation  indices.
Conclusions:  The  VMAT  treatment  planning  with  the least  effect  on dose  distribution  caused  by  rectal  gas
was  shown  to  be a full  arc.










Radiotherapy has undergone a series of advancements in recent
decades, from the technique of intensity modulated radiation
therapy (IMRT) to the development of volumetric modulated arc
therapy (VMAT). VMAT is a therapeutic technique that allows a
simultaneous modulation of a number of photons emitted by alter-
ing the treatment aperture shape of the multi-leaf collimator (MLC),
the dose rate, and the speed of the gantry.1 There are many reports
that VMAT has a shorter treatment time than IMRT and can achieve
a similar dose distribution.2–4 Consequently, in the field of radia-
tion therapy, VMAT has become more popular than IMRT due to
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1507-1367/© 2020 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reshe increase in the number of cases and the expansion of indica-
ions for the treatment site. Especially for prostate cancer, VMAT is
erformed at many institutions to reduce treatment time.
IMRT in prostate cancer has been reported to render good out-
omes with a mild incidence of acute and late toxicity.5 Radiation
herapy for prostate cancer requires high doses of about 80 Gy for
ocal control.6 Therefore, for prostate cancer VMAT, the National
omprehensive Cancer Network guidelines6 recommend image-
uided radiation therapy (IGRT). IGRT improves the precision of
he treatment delivery through the comparison of pre-treatment
nd treatment planning images to confirm the irradiation position
atching.
There are two  main types of IGRT position matching. One is
ased on bone matching using two-dimensional images such as kV-
maging or an electric portal imaging device. The other is based on
he target position using three-dimensional images such as cone-
eam computed tomography (CBCT). The prostate is a target that is
isplaced and deformed independently of the bone structure and
erved.
Reports of Practical Oncology and Radiotherapy 25 (2020) 974–980
Table 1
Dose-volume constraints used in treatment planning.
Structurer Dose constraint
PTV excluding rectum D95% = 100%
Maxdose < 110%
CTV V100%(%) ≥ 99.5%
Rectum V40 Gy(%) ≤ 50%
V60 Gy(%) ≤ 25%
V70 Gy(%) ≤ 15%
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moves due to the effects of the bladder and rectum filling. Therefore,
the filling condition of the bladder and rectum during each radia-
tion treatment must be as close as possible to the state of the CT
taken for radiation treatment planning. Preprocessing for radiation
therapy for prostate cancer includes urine from the bladder and rec-
tal contents such as feces and gas. If preprocessing is not possible,
it is difficult to deliver the prostate treatment daily in response to
prostate displacement and deformation due to bone alignment. In
this situation, target matching by CBCT is recommended.7 Previous
reports have shown that rectal gas has the most significant effect
on prostate displacement and deformation compared to others.8,9
Moreover, there has been a report investigating the effect of rec-
tal gas, which is not present at the time of treatment planning for
prostate IMRT and VMAT, on the dose distribution when rectal gas
is present during actual treatment.2 This report2 assumes that there
is no displacement or change in the position of the prostate, sug-
gesting that the presence or absence of rectal gas has less effect on
the dose distribution during IMRT than VMAT. However, VMAT in
this report2 is a treatment plan in a full arc. Hence, the same result
is not always obtained when a part of the gantry rotation angle is
limited.
2. Aim
The purpose of this study was to investigate the impact of rectal
gas on dose distribution in VMAT treatment plans in which the full
arc and gantry rotation angles were partially restricted.
3. Materials and methods
This study involved fifteen patients who underwent prostate
VMAT at our institution. An anisotropic analytical algorithm (AAA)
in the Eclipse (Varian Medical Systems, Palo Alto, CA., USA) treat-
ment planning system (TPS, version 11.0.31) was used to calculate
the dose. The Optima CT 580 W (General Electric Medical Systems,
Waukesha, WI., USA) CT system was used for imaging, with a slice
thickness of 2.5 mm.  The TrueBeam (Varian Medical Systems, Palo
Alto, CA, USA) linear accelerator used an energy setting of 10×.
Clinical target volume (CTV) and rectum and bladder delineation
settings were performed according to the method of Sasaki et al.2
The planning target volume (PTV) was set at 6 mm only behind the
CTV and 8 mm in the other directions. In this study, it was assumed
that there was no displacement or deformation of the prostate
when evaluating the effect of rectal gas on the dose distribution. To
evaluate differences in rectal gas dose distributions, a Hounsfield
Unit (HU) −950 was simulated for the overlapping part (overlap) of
the rectum and PTV. This retrospective study was approved by the
Institutional Review Board of our institution (Approval No. 3434).
3.1. Treatment planning
Full arc and limited gantry rotation angle with VMAT were
the two arcs. The VMAT of the full arc was 181◦–179◦ in the
clockwise (CW) direction and 179◦–181◦ in the counterclock-
wise (CCW) direction. Three partial arcs with a limited gantry
rotation angle were created: 200◦–160 ◦CW and 160◦–200 ◦CCW;
220◦–140 ◦CW and 140◦–220 ◦CCW; and finally, 240◦–120 ◦CW and
120◦–240 ◦CCW. These three partials arcs will be referred to as
200◦–160◦, 220◦–140◦, 240◦–120◦, respectively, in the rest of this
paper. The collimator rotation angles of 30◦ and 330◦ were adopted
in both VMAT plans. The prescription dose in this study was
78 Gy/39 fractions and was a dose (D95%) that included 95% of the
volume of the PTV excluding rectum obtained by subtracting the
rectum overlap from the PTV.
4
o
975Bladder V40 Gy(%) ≤ 50%
V65 Gy(%) ≤ 25%
In this study, dose calculations were performed using two types
f structure sets. The first is the original structure set, CTV, PTV
xcluding rectum, the rectum, and the bladder used clinically. The
econd is a structure set (simulated gas structure set) in which the
verlap is overwritten with HU as gas, as described above. The rec-
al gas volume relative to the rectum contour volume used in the
reatment plan was  less than 5% in all the cases. In all the cases, the
our treatment plans described above were created for the origi-
al structure set. Then, in order to evaluate the effect of rectal gas
n the dose distribution, re-calculation was performed using the
imulated gas structure set with the same iso-center as the original
tructure set. During the re-calculation, the optimization work was
ot performed again, and the gantry speed, MLC  shape, and dose
ate did not change.
.2. Evaluation of original VMAT treatment plan
If the difference between the four plans could be minimized, it
ill be possible to quantify/study the effect of rectal gas on dose dis-
ribution. Therefore, significance tests of the four treatment plans
reated using the original structure set were performed using a
aired t-test of parametric statistics. The significance level was set
t p < 0.05. The evaluation items were selected based on the dose
onstraints of our institution shown in Table 1.
.3. Effect of dose distribution with and without rectal gas
Next, using the simulated gas structure set, the difference
etween the recalculated dose distribution and the original VMAT
reatment plan was evaluated. The purpose of this study was to
xamine the variation of the dose distribution among the four
riginal treatment plans depending on the presence or absence
f rectal gas. Therefore, we  carried out the recalculations and no
e-optimization was performed. The PTV excluding rectum, the
TV, the rectum, and the bladder were evaluated using the 3DVH
ersion 2.2.1 (Sun Nuclear Corporation, Melbourne, FL, USA), a
hree-dimensional (3D) dose verification software. The evaluation
tems were dose difference (DD), distance to agreement (DTA),
nd gamma  analysis (GA). DD was evaluated at 1%, 2%, and 3%;
TA at 1 mm,  2 mm,  and 3 mm;  and GA at 1 mm/1%, 2 mm/2%, and
 mm/3%. In this study, 3DVH was  used to objectively assess the
ifferences in the dose distribution with and without simulated
ectal gas in the same treatment plan. To evaluate the effect of dose
istribution with and without rectal gas on each treatment plan, a
ignificance test was  performed using a paired t-test of parametric
tatistics. The significance level was set at p < 0.05.
. Result.1. Original VMAT treatment plan
Table 2 shows the results of the treatment planning for four
riginal VMATs based on the dose constraints shown in Table 1.
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Table  2
Dosimetric comparison of organs at risk and target dose of full arc and limited gantry rotation angle with volumetric modulated arc therapy plans.
Structurer Dose constraint Technique
Full arc 200◦–160◦ 220◦–140◦ 240◦–120◦
CTV V100%(%) 99.97 ± 0.04 99.97 ± 0.04 99.98 ± 0.03 99.94 ± 0.16
Rectum V40 Gy(%) 30.60 ± 3.21 30.64 ± 3.47 30.76 ± 3.65 31.23 ± 4.01
V60  Gy(%) 15.24 ± 1.96 15.43 ± 2.11 15.74 ± 2.18 16.13 ± 2.36
V70  Gy(%) 7.68 ± 1.29 8.15 ± 1.45 8.48 ± 1.50 8.74 ± 1.65
V75  Gy(%) 3.03 ± 1.14 3.71 ± 1.42 4.02 ± 1.44 4.22 ± 1.55
Bladder  V40 Gy(%) 31.59 ± 6.61 31.95 ± 7.23 31.84 ± 7.43 32.76 ± 8.77
V65  Gy(%) 11.83 ± 4.29 11.78 ± 4.35 11.97 ± 4.36 12.37 ± 4.47













CTV V100%(%) 0.772 0.670 0.463 0.478 0.528 0.389
Rectum V40 Gy(%) 0.947 0.947 0.682 0.924 0.670 0.742
V60  Gy(%) 0.806 0.521 0.272 0.697 0.397 0.637
V70  Gy(%) 0.359 0.127 0.060 0.538 0.306 0.661
V75  Gy(%) 0.160 0.045 0.024 0.547 0.351 0.722
Bladder V40 Gy(%) 0.889 0.922 0.683 0.969 0.784 0.760
V65  Gy(%) 0.972 0.933 0.740 0.906 0.716 0.805
Fig. 1. The average dose-volume histogram of (a) clinical target volume (CTV) and (b) rectum in the four volumetric modulated arc therapy treatment plans.
 angleFig. 2. The average dose distribution the full arc and limited gantry rotationFig. 1 shows the average dose-volume histogram (DVH) of CTV and
organ at risk (OAR) in the four original VMAT treatment plans in this




976 with VMAT plans. (a) Full arc, (b) 200◦–160◦ , (c) 220◦–140◦ , (d) 240◦–120◦ .how any characteristic change in the difference between the VMAT
lans. At the dose constraint in the rectum, the shorter the gantry
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rectum. Moreover, the shorter the gantry rotation angle range, the
greater the variation among cases. There was a significant differ-
ence between the treatment plans for rectum V75 Gy [full arc and
220◦–140◦ (p = 0.045) and full arc and 240◦–120◦ (p = 0.024)]. At the
bladder in V40 Gy, the shorter the gantry rotation angle range, the
smaller the dose that can be reduced by the bladder, and the larger
the variation, as was the point of the dose constraint of the rec-
tum. Bladder V65 Gy did not show any characteristic changes in
the differences in the VMAT plan.
4.2. Effect of dose distribution with and without rectal gas
Table 3 shows the difference in relative doses at the point of
dose constraint depending on the presence or absence of rectal gas.
The reference dose distribution is the original structure set without
simulated gas in the rectum. Fig. 3 shows the CTV and rectum DVH
with and without rectal gas in the four VMAT treatment planning
techniques in this study. In PTV excluding rectum D95% and CTV
V100%, the dose of the simulated gas structure set tended to be
smaller than that of the original structure set, resulting in a dose
reduction of about 0.28–0.68%. However, no characteristic change
was observed between the treatment planning techniques.
For the rectum, the dose tended to be higher in the simulated gas
structure set than in the original structure set at V40 Gy and V60 Gy.
Contrarily, in V70 Gy and V75 Gy, the dose tended to be lower in
the simulated gas structure set than in the original structure set.
The dose relationship between the original structure set and the
simulated gas structure set was reversed at a dose of around 60 Gy
from the DVH shown in Fig. 3. Additionally, in the case of rectums
V40 Gy and V70 Gy, the shorter the gantry rotation angle range,
the more significant the dose difference compared to the original
structure set. However, no characteristic changes were observed
in V60 Gy and V75 Gy. Furthermore, there was no characteristic
change in the variability between cases with or without rectal gas
in the four VMAT treatment planning techniques.
Regarding the bladder, no characteristic changes were observed
in the treatment planning techniques for the four VMATs with or
without rectal gas, and no variation was observed between the
cases.
Table 4 shows the results of DD, DTA, and GA, which are indica-
tors of the degree of coincidence of the dose distribution with and
without rectal gas for each treatment plan. In the PTV excluding
rectum and CTV, the full arc was the most suitable treatment plan-
ning technique for DD, DTA, and GA pass rate result. In CTV, there
were significant differences between the full arc and the 220◦–140◦
treatment planning techniques for DTA 1 mm (p = 0.042), 2 mm
(p = 0.030), and 3 mm (p = 0.035). In CTV, there was a signifi-
cant difference in DTA 2 mm (p = 0.043) between the full arc and
the 240◦–120◦ treatment planning technique. No characteristics
changes were observed in CTV and PTV excluding rectum, among
other treatment planning techniques.
When looking at the impact on the rectum, there was  no signif-





Relative dose difference at the point of dose constraint with and without rectal gas.
Structurer Dose constraint Technique
Full arc 
CTV V100%(%) −0.51 ± 0.56 
Rectum V40 Gy(%) 0.79 ± 1.06 
V60  Gy(%) 0.55 ± 1.06 
V70  Gy(%) −4.10 ± 3.66 
V75  Gy(%) −29.96 ± 19.24 
Bladder  V40 Gy(%) −0.02 ± 0.25 
V65  Gy(%) −0.02 ± 0.70 
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hen the gantry rotation angle range was short, the pass rate
ended to reduce for all evaluation indices. There was a signif-
cant difference in GA 1 mm/1% (p = 0.032) between the full arc
nd 240◦–120◦ treatment planning techniques. No characteristic
hanges were observed between the other treatment planning
echniques.
The bladder showed no characteristic change between the treat-
ent planning techniques in any of the evaluation indices. No
ignificant difference was observed in any of the evaluation indices.
. Discussion
Based on the results shown in Table 2, Fig. 1 (a), and Fig. 2, there
as no significant difference between the treatment planning tech-
iques concerning the target coverage, and it is considered that the
reatment planning quality was  practically the same. In contrast,
ectum V75 Gy showed significant differences between the full arc
nd the 220◦–140◦, and the full arc and the 240◦–120◦ treatment
lans. However, the DVH shape of the rectum shown in Fig. 1 (b)
hows a similar shape among the four treatment planning tech-
iques. From the dose distribution between the treatment planning
echniques shown in Fig. 2, the dose intervals in the anterior-
osterior direction to the rectum are almost the same from a high
ose to low dose. Therefore, for the rectum, it is considered that the
reatment plan quality was virtually the same among the four treat-
ent planning techniques. For the bladder, as shown in Table 2, the
-values between treatment planning techniques are large, and
here is no characteristic difference. Therefore, it is considered that
here is no significant difference in the dose distribution for CTV
nd OAR among the four treatment planning techniques, and it can
e considered that the dose distribution is similar.
Prior reports have detailed their findings regarding the effects of
ectal gas on the dose distribution of prostate IMRT and VMAT.2 This
tudy takes this work further by investigating the effect of rectal
as on dose distribution by overwriting the HU value at −950 in
he region where the PTV and rectum overlap, assuming that there
s no positional displacement and deformation of CTV and OAR.
he X-ray energy used in this study was 10×,  but the past report
as  15×.  Similar to the treatment planning technique in previous
tudies, this study uses a full arc, showing different values of the
D, DTA, and GA pass ratio results. However, the dose trends for the
TV and rectum using the original structure set and the simulated
as structure set were similar. Therefore, it is considered that the
ifference in the pass ratio is due to the difference in energy. The
elationship between the pass ratio of DD and DTA is the same as
n previous reports. Specifically, the pass ratio of DD  was  higher in
he CTV than in DTA, but the pass ratio of DTA in the rectum was
igher than that of DD. From these facts, it can be inferred that the
ffect of rectal gas is smaller at low energies. However, care must
e taken because the results of the pass rate may  differ depending
n the case.
Ogino et al. in a previous study evaluated the relationship
etween the intra-fractional motion of the prostate in patients and
200◦–160◦ 220◦–140◦ 240◦–120◦
−0.60 ± 0.66 −0.68 ± 0.74 −0.58 ± 0.83
0.92 ± 1.15 1.06 ± 1.15 1.23 ± 1.26
0.53 ± 1.09 0.60 ± 0.96 0.68 ± 0.93
−4.22 ± 3.67 −4.40 ± 3.81 −4.91 ± 4.28
−28.13 ± 20.08 −27.64 ± 18.07 −30.06 ± 20.57
−0.04 ± 0.24 −0.05 ± 0.23 −0.06 ± 0.24




































CTV DD1%(%) 93.50 ± 5.59 91.78 ± 6.41 90.85 ± 6.92 91.91 ± 6.63 0.440 0.258 0.484 0.704 0.956 0.670
DD2%(%) 98.53 ± 2.35 97.79 ± 3.01 97.36 ± 3.33 98.02 ± 2.64 0.463 0.278 0.583 0.711 0.828 0.552
DD3%(%) 99.71 ± 0.69 99.41 ± 1.21 99.23 ± 1.54 99.55 ± 0.93 0.414 0.276 0.598 0.715 0.726 0.489
DTA1  mm(%) 75.64 ± 9.79 71.65 ± 12.57 66.93 ± 12.41 67.18 ± 12.96 0.341 0.042 0.054 0.310 0.346 0.958
DTA2  mm(%) 91.55 ± 4.29 89.05 ± 5.77 86.92 ± 6.49 87.36 ± 6.30 0.189 0.030 0.043 0.351 0.451 0.852
DTA3  mm(%) 96.80 ± 2.06 95.25 ± 3.26 94.18 ± 4.01 94.76 ± 3.22 0.134 0.035 0.051 0.429 0.680 0.666
GA1  mm / 1%(%) 94.99 ± 4.60 92.84 ± 5.90 91.80 ± 6.54 92.74 ± 6.10 0.277 0.135 0.265 0.651 0.964 0.687
GA2  mm / 2%(%) 99.52 ± 0.98 98.99 ± 1.84 98.73 ± 2.07 99.24 ± 1.31 0.338 0.198 0.512 0.719 0.675 0.431
GA3  mm / 3%(%) 99.96 ± 0.17 99.81 ± 0.49 99.75 ± 0.61 99.95 ± 0.15 0.359 0.255 0.908 0.745 0.329 0.236
Rectum  DD1%(%) 86.46 ± 14.76 83.69 ± 15.78 80.21 ± 16.62 78.08 ± 17.49 0.623 0.285 0.167 0.561 0.365 0.735
DD2%(%) 95.14 ± 9.85 93.63 ± 10.85 91.94 ± 11.38 90.89 ± 12.72 0.692 0.417 0.316 0.681 0.523 0.814
DD3%(%) 97.18 ± 6.84 96.49 ± 7.62 95.81 ± 8.29 95.45 ± 9.08 0.797 0.626 0.562 0.817 0.737 0.911
DTA1  mm(%) 99.68 ± 0.50 99.35 ± 1.01 99.07 ± 1.48 98.85 ± 1.61 0.273 0.151 0.073 0.550 0.313 0.692
DTA2  mm(%) 99.98 ± 0.04 99.93 ± 0.12 99.89 ± 0.20 99.89 ± 0.22 0.165 0.118 0.152 0.508 0.539 -
DTA3  mm(%) 99.99 ± 0.03 99.99 ± 0.04 99.99 ± 0.04 99.99 ± 0.03 0.559 0.559 - - 0.559 0.559
GA1  mm / 1%(%) 99.74 ± 0.52 99.39 ± 1.02 99.07 ± 1.48 98.72 ± 1.61 0.255 0.118 0.032 0.498 0.185 0.537
GA2  mm / 2%(%) 99.99 ± 0.03 99.96 ± 0.11 99.93 ± 0.18 99.93 ± 0.15 0.253 0.184 0.108 0.547 0.485 -
GA3  mm / 3%(%) 100.00 ± 0.00 100.00 ± 0.00 99.99 ± 0.03 100.00 ± 0.00 - 0.334 - 0.334 - 0.334
Bladder  DD1%(%) 99.75 ± 0.53 99.69 ± 0.56 99.62 ± 0.66 99.63 ± 0.67 0.792 0.566 0.590 0.745 0.770 0.978
DD2%(%) 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 - - - - - -
DD3%(%) 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 - - - - - -
DTA1  mm(%) 99.65 ± 0.42 99.61 ± 0.51 99.57 ± 0.52 99.60 ± 0.48 0.787 0.618 0.748 0.833 0.971 0.856
DTA2  mm(%) 99.85 ± 0.18 99.85 ± 0.22 99.85 ± 0.18 99.87 ± 0.18 0.928 - 0.763 0.928 0.721 0.763
DTA3  mm(%) 99.91 ± 0.12 99.92 ± 0.10 99.92 ± 0.09 99.93 ± 0.13 0.874 0.870 0.669 - 0.756 0.749
GA1  mm / 1%(%) 100.00 ± 0.00 99.99 ± 0.04 100.00 ± 0.00 100.00 ± 0.00 0.164 - - 0.164 0.164 -
GA2  mm / 2%(%) 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 - - - - - -
GA3  mm / 3%(%) 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 - - - - - -
978





























Fig. 3. Clinical target volume (CTV) and rectum dose-volume histogram with and
modulated arc therapy plans (a) Full arc, (b) 200◦–160◦ , (c) 220◦–140◦ , (d) 240◦–12
gas present in the rectal contents. They concluded that the pres-
ence of rectal gas was associated with prostate displacement and
rectal movement in patients.10 Another study performed IGRT to
study the variability of delivery dose to the prostate, rectum, and
bladder during a full course of external beam radiotherapy; the
IGRT images acquired were CBCTs of MV beams from Tomother-
apy, which showed large variation in delivery dose to the prostate,
rectum, and bladder.11
Other reports indicated that patients with a bulging rectum at
the time of treatment planning CT scans had worse biochemical
progression-free survival than patients with an empty rectum.12–14
Rectal volume is known to decrease during the treatment, espe-
cially in patients with large rectal volumes during planning CT. As
a result, the prostate gland may  move posteriorly from its prede-
fined PTV and cancer may  not be adequately treated. This confirms
that IGRT based on bone landmarks is inadequate and that more
sophisticated IGRT techniques are needed.
However, even when IGRT is performed, there may  be no rec-
tal gas present at the time of treatment planning CT scan, but gas
may  be present in the rectum on the CBCT taken immediately before
the treatment. In some cases, this is experienced without deformity
and displacement of the prostate. In the present study, we  investi-
gate the effect of the presence or absence of rectal gas on the dose
distribution in the absence of prostate deformity and displacement.
The purpose of this study was to investigate a VMAT treatment
plan in which rectal gas had little effect on dose distribution. DD,
DTA, and GA evaluated the differences between the full arc and
VMAT treatment plans with a limited gantry rotation angle. The
VMAT treatment plan with the least effect of rectal gas was  the
full arc, and it was found that the shorter the gantry rotation angle
range, the higher the effect of rectal gas on the dose distribution. The
dose distribution among the four treatment planning techniques is
the same from the DVH shape of CTV, and OAR was shown in Fig. 1,
and the dose distribution shown in Fig. 2. Fig. 2 shows that when





979out rectal gas in the Full arc and limited gantry rotation angle with volumetric
nsured, the dose distribution in the direction in which no photons
nter is reduced without being enlarged. Therefore, the dose distri-
ution becomes steep from the back of the CTV to the anterior wall
f the rectum and the horizontal direction. It is thought that the
teep dose distribution is greatly influenced by scattered radiation
ue to the presence and absence of rectal gas.
However, when investigating the effects of rectal gas, this study
imulated the overwriting of the HU value in the overlap region
nd assumed that there was no positional displacement or defor-
ation of CTV and OAR. In fact, during treatment, CTV and OAR are
isplaced and deformed due to rectal stool, gas, and urine capacity
f the bladder. Therefore, it is necessary to evaluate the effect on the
ose distribution in the case of positional displacement and defor-
ation in CTV and OAR in the future.15 It is also reported that the
ose calculation algorithm used in this study, AAA, does not accu-
ately calculate the change in density in non-uniform regions.16
herefore, the dose to the anterior wall of the rectum may  be over-
stimated, and the dose to the posterior wall of the CTV may  be
nderestimated. In the future, the dose calculation algorithm to
e used will be studied using Acuros XB17 or XVMC,18 which is
quivalent to the Monte Carlo simulation.
To the best of our knowledge, our study is pioneering for inves-
igating the dose effect of rectal gas at each treatment in prostate
MAT. Therefore, the present study shows that the improved per-
ormance with full arc irradiation compared to partial irradiation
n the presence of rectal gas, leads to a better understanding when
erforming prostate VMAT.
. Conclusions
In this study, we  investigated the effect of rectal gas on dose
istribution during prostate cancer using a VMAT treatment plan.
pecially, we  investigated the impact of rectal gas on a variety of
MAT treatment plans with a partial limitation of full arc and gantry
otation angles. The VMAT treatment planning with the least effect
calculation algorithm for lung SBRT plans. Phys Med. 2017;44:86–95.
18. Nakamura M, Ishihara Y, Matsuo Y, et al. Quantification of the kV X-ray imagingM.  Sasaki et al. 
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